Showing 2,341 - 2,360 results of 10,589 for search 'CITV~', query time: 1.26s Refine Results
  1. 2341
  2. 2342
  3. 2343

    Remote Monitoring of Chemotherapy-Induced Peripheral Neuropathy by the NeuroDetect iOS App: Observational Cohort Study of Patients With Cancer by Ciao-Sin Chen, Michael P Dorsch, Sarah Alsomairy, Jennifer J Griggs, Reshma Jagsi, Michael Sabel, Amro Stino, Brian Callaghan, Daniel L Hertz

    Published 2025-02-01
    “…ResultsOf the 45 patients who completed functional assessments and neurological examinations, 24 had CIPN-f, and 29 had CIPN-h. The NeuroDetect Model could discriminate between patients with and those without CIPN-f (area under the curve=83.8%, comparison with no information rate P=.02) but not CIPN-h (area under the curve=67.9%, P=.18). …”
    Get full text
    Article
  4. 2344

    The distribution, phenology, host range and pathogen prevalence of Ixodes ricinus in France: a systematic map and narrative review by Perez, Grégoire, Bournez, Laure, Boulanger, Nathalie, Fite, Johanna, Livoreil, Barbara, McCoy, Karen D., Quillery, Elsa, René-Martellet, Magalie, Bonnet, Sarah I.

    Published 2023-09-01
    “…The tick Ixodes ricinus is the most important vector species of infectious diseases in European France. Understanding its distribution, phenology, and host species use, along with the distribution and prevalence of associated pathogens at a national scale is essential for developing prevention strategies. …”
    Get full text
    Article
  5. 2345
  6. 2346
  7. 2347
  8. 2348

    ANTIGENIC AND PROTECTIVE PROPERTIES OF EXPERIMENTAL ASSOCIATED VIRUS VACCINE AGAINST SHEEP POX AND GOAT POX by A. V. Konstantinov, S. K. Starov, V. I. Diev, N. V. Moroz, E. V. Kurnenkova, D. К. Basova, А. V. Kononov, K. Yu. Fedoseyev

    Published 2018-07-01
    “…Studies have been carried on antigenic and protective activity of the experimental associated vaccine containing, in the field vaccination dose, antigens of the attenuated ARRIAH strain of the sheep pox virus and ARRIAH 2003 strain of the goat pox virus in the ratio of 4.24 and 4.24 lg TCD50/cm3, 4.18 and 4.37 lg TCD50/cm3 and 4.37 and 4.18 lg TCD50/cm3 respectively, as well as monovalent vaccines with the infectious activity of these strains with a titer of 4.5 lg TCD50/cm3. …”
    Get full text
    Article
  9. 2349

    Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia by Camille Tessier, Richard LeBlanc, Jean Roy, Sabrina Trudel, Julie Côté, Marc Lalancette, Jean‐Samuel Boudreault, Émilie Lemieux‐Blanchard, Rayan Kaedbey, Michel Pavic

    Published 2024-09-01
    “…The median progression‐free survival (PFS) to frontline treatment and overall survival (OS) were, respectively, 4.8 (95% CI, 0.4–9.2) and 18.3 months (95% CI, 0.0–39.0) for pPCL and 0.8 (95% CI, 0.5–1.1) and 1.2 months (95% CI, 0.9–1.5) for sPCL (both p < 0.001). …”
    Get full text
    Article
  10. 2350
  11. 2351
  12. 2352

    Non-pharmacological interventions for the reduction and maintenance of blood pressure in people with prehypertension: a systematic review protocol by Paul Rutter, Andrew Clegg, Valerio Benedetto, Caroline Watkins, Nefyn Williams, Joseph Spencer, Lucy Hives, Emma P Bray, Cath Harris, Rachel F Georgiou, Nafisa Iqbal

    Published 2024-01-01
    “…Results will be published in a peer-reviewed journal, disseminated via the wider study website and shared with the study sites and participants.Registration details The review is registered with PROSPERO (CRD420232433047).…”
    Get full text
    Article
  13. 2353
  14. 2354
  15. 2355
  16. 2356
  17. 2357
  18. 2358
  19. 2359
  20. 2360